Aprogen Medicines Inc. (KRX:007460)

Aprogen Medicines Statistics

Total Valuation

KRX:007460 has a market cap or net worth of KRW 214.16 billion. The enterprise value is 651.82 billion.

Market Cap	214.16B
Enterprise Value	651.82B

Important Dates

The last earnings date was Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:007460 has 305.95 million shares outstanding. The number of shares has increased by 15.07% in one year.

Current Share Class	305.95M
Shares Outstanding	305.95M
Shares Change (YoY)	+15.07%
Shares Change (QoQ)	+0.62%
Owned by Insiders (%)	6.99%
Owned by Institutions (%)	2.11%
Float	186.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.68
PB Ratio	0.43
P/TBV Ratio	2.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.74
EV / Sales	5.12
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.95

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.46.

Current Ratio	1.02
Quick Ratio	0.71
Debt / Equity	0.46
Debt / EBITDA	n/a
Debt / FCF	-5.96
Interest Coverage	-39.94

Financial Efficiency

Return on equity (ROE) is -29.14% and return on invested capital (ROIC) is -9.77%.

Return on Equity (ROE)	-29.14%
Return on Assets (ROA)	-8.80%
Return on Invested Capital (ROIC)	-9.77%
Return on Capital Employed (ROCE)	-17.98%
Revenue Per Employee	497.39M
Profits Per Employee	-216.81M
Employee Count	256
Asset Turnover	0.18
Inventory Turnover	1.45

Taxes

Income Tax	-2.14B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.47% in the last 52 weeks. The beta is 0.44, so KRX:007460's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-47.47%
50-Day Moving Average	666.56
200-Day Moving Average	745.31
Relative Strength Index (RSI)	66.17
Average Volume (20 Days)	3,412,564

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:007460 had revenue of KRW 127.33 billion and -55.50 billion in losses. Loss per share was -198.97.

Revenue	127.33B
Gross Profit	31.43B
Operating Income	-101.05B
Pretax Income	-137.85B
Net Income	-55.50B
EBITDA	-76.24B
EBIT	-101.05B
Loss Per Share	-198.97

Balance Sheet

The company has 147.91 billion in cash and 229.27 billion in debt, giving a net cash position of -81.36 billion or -265.93 per share.

Cash & Cash Equivalents	147.91B
Total Debt	229.27B
Net Cash	-81.36B
Net Cash Per Share	-265.93
Equity (Book Value)	498.92B
Book Value Per Share	490.03
Working Capital	5.53B

Cash Flow

In the last 12 months, operating cash flow was -23.15 billion and capital expenditures -15.31 billion, giving a free cash flow of -38.46 billion.

Operating Cash Flow	-23.15B
Capital Expenditures	-15.31B
Free Cash Flow	-38.46B
FCF Per Share	-125.69

Margins

Gross margin is 24.68%, with operating and profit margins of -79.36% and -43.59%.

Gross Margin	24.68%
Operating Margin	-79.36%
Pretax Margin	-108.26%
Profit Margin	-43.59%
EBITDA Margin	-59.88%
EBIT Margin	-79.36%
FCF Margin	n/a

Dividends & Yields

KRX:007460 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.07%
Shareholder Yield	n/a
Earnings Yield	-25.92%
FCF Yield	-17.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 28, 2022. It was a reverse split with a ratio of 0.3333333333.

Last Split Date	Dec 28, 2022
Split Type	Reverse
Split Ratio	0.3333333333

Scores

KRX:007460 has an Altman Z-Score of -0.5 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.5
Piotroski F-Score	1